The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
On December 6, 2023, Medtronic Delivered Notice To EOFlow That It Had Exercised Its Right To Terminate Agreements Based Upon Multiple Breaches Under Agreements – Filing
